We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.44%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$10.4B
AUM Growth
+$576M
Cap. Flow
+$80.3M
Cap. Flow %
0.78%
Top 10 Hldgs %
38.6%
Holding
1,407
New
91
Increased
858
Reduced
433
Closed
18

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$12.5M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$12.5M
3
META icon
Meta Platforms (Facebook)
META
+$8.69M
4
V icon
Visa
V
+$8.21M
5
AMZN icon
Amazon
AMZN
+$6.1M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$7.31M
2
VRSK icon
Verisk Analytics
VRSK
+$5.19M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.16M
4
IT icon
Gartner
IT
+$4.49M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$3.73M

Sector Composition

Rank Sector Weight
1 Technology 35.83%
2 Consumer Discretionary 11.41%
3 Financials 11.04%
4 Healthcare 10.64%
5 Communication Services 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSHA icon
1376
Taysha Gene Therapies
TSHA
$1.94B
$21.8K ﹤0.01%
+10,869
New +$23.8K
EAF icon
1377
GrafTech
EAF
$194M
$21.3K ﹤0.01%
1,616
+103
+7% +$859
SMRT icon
1378
SmartRent
SMRT
$261M
$21.2K ﹤0.01%
12,256
– –
ESPR
1379
DELISTED
Esperion Therapeutics
ESPR
$19.9K ﹤0.01%
12,086
-359
-3% -$725
CERS icon
1380
Cerus
CERS
$548M
$19.5K ﹤0.01%
11,234
-226
-2% -$474
LAZR
1381
DELISTED
Luminar Technologies
LAZR
$19.5K ﹤0.01%
1,448
+43
+3% +$780
AKBA icon
1382
Akebia Therapeutics
AKBA
$260M
$18.1K ﹤0.01%
13,701
– –
OCGN icon
1383
Ocugen
OCGN
$465M
$16.6K ﹤0.01%
16,751
+890
+6% +$1.22K
MVIS icon
1384
Microvision
MVIS
$57.5M
$15.2K ﹤0.01%
891
+35
+4% +$545
NKTR icon
1385
Nektar Therapeutics
NKTR
$2.55B
$14K ﹤0.01%
720
-44
-6% -$839
LYEL icon
1386
Lyell Immunopharma
LYEL
$358M
$13.9K ﹤0.01%
503
– –
SLDP icon
1387
Solid Power
SLDP
$543M
$13.6K ﹤0.01%
+10,099
New +$16K
FCEL icon
1388
FuelCell Energy
FCEL
$1.54B
$11.6K ﹤0.01%
1,016
+44
+5% +$652
BLUE
1389
DELISTED
bluebird bio
BLUE
$6.15K ﹤0.01%
592
– –
DIOD icon
1390
Diodes
DIOD
$4.18B
– –
-2,899
Closed -$209K
EFV icon
1391
iShares MSCI EAFE Value ETF
EFV
$31.6B
– –
-35,991
Closed -$1.76M
GH icon
1392
Guardant Health
GH
$22.6B
– –
-7,479
Closed -$216K
HELE icon
1393
Helen of Troy
HELE
$674M
– –
-3,210
Closed -$298K
HP icon
1394
Helmerich & Payne
HP
$4.24B
– –
-6,163
Closed -$223K
IEMG icon
1395
iShares Core MSCI Emerging Markets ETF
IEMG
$162B
– –
-64,472
Closed -$3.18M
IRTC icon
1396
iRhythm Holdings
IRTC
$3.83B
– –
-1,954
Closed -$210K
MP icon
1397
MP Materials
MP
$10.5B
– –
-14,298
Closed -$182K
PGNY icon
1398
Progyny
PGNY
$1.98B
– –
-11,314
Closed -$324K
SDRL icon
1399
Seadrill
SDRL
$3.03B
– –
-4,718
Closed -$243K
SITC icon
1400
SITE Centers
SITC
$156M
– –
-15,468
Closed -$175K
53 54 55
56
57

Similar funds

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $16.1B AUM 40.83% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $16.6B AUM 3.91% 1-Year Est. Return

Xponance's Q3 2024 Portfolio in Review

As of Q3 2024, Xponance held 1,407 positions worth $10.4B, up 5.9% from $9.78B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Xponance's Q3 2024 filing shows 91 new, 858 increased, 433 reduced and 18 closed positions. Its largest new stake was Smurfit Westrock: 106,066 shares worth $5.24M. The largest sale was Eli Lilly, an estimated $7.31M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Xponance's largest Q3 2024 buy was Smurfit Westrock: 106,066 shares worth $5.24M.
  • Xponance added most to Broadcom in Q3 2024, an estimated $12.5M increase.
  • Xponance's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $7.31M.
  • Xponance fully exited Invesco S&P 500 Concentrated QVM ETF in Q3 2024, selling an estimated $3.61M.
  • Xponance's ten largest holdings make up 39% of its $10.4B portfolio in Q3 2024.
  • Xponance opened 91 new positions and closed 18 in Q3 2024.
  • Xponance's portfolio value rose 5.9% quarter-over-quarter to $10.4B.

Based on Xponance's 13F filing for Q3 2024, filed 12 Nov 2024.